Spectroscopic Insights into Nanodiamond-Doxorubicin Interactions in Drug Delivery Systems for Potential Cancer Treatment: "What Is Essential Is Invisible to the Eye".

Danica Jović, Branislav Jović, Ivana Borišev, Višnja Bogdanović, Aleksandar Djordjevic

Abstract read

In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Danica JovićDepartment of Chemistry, Biochemistry, and Environmental Protection, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.ORCID 0000-0003-4240-3732

Branislav JovićDepartment of Chemistry, Biochemistry, and Environmental Protection, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.ORCID 0000-0002-4018-8461

Ivana BoriševDepartment of Chemistry, Biochemistry, and Environmental Protection, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.ORCID 0000-0002-3884-639X

Višnja BogdanovićOncology Institute of Vojvodina, Put doktora Goldmana 4, 21204 Sremska Kamenica, Serbia.

Aleksandar DjordjevicDepartment of Chemistry, Biochemistry, and Environmental Protection, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.ORCID 0000-0003-4120-7318

Funding

Ministry of Science, Technological Development and Innovation of the Republic of Serbia Grants No. 451-03-33/2026-03/200125 and 451-03-34/2026-03/200125

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer cell linesDLS measurementsdoxororubicinnanocarriersnanodiamondsnon-covalent drug deliveryUV–VIS spectroscopy

Identifiers

PMID42076090

DOI10.3390/pharmaceutics18040438

PMCPMC13119105

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.